Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Neurelis Inc.
DescriptionIntranasal formulation of lorazepam
Molecular Target GABA A receptor
Mechanism of ActionGABA A receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAnxiety
Indication DetailsTreat acute anxiety
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today